154 related articles for article (PubMed ID: 32432874)
1. High-Throughput Screening for the Discovery of Enzyme Inhibitors.
Lloyd MD
J Med Chem; 2020 Oct; 63(19):10742-10772. PubMed ID: 32432874
[TBL] [Abstract][Full Text] [Related]
2. Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors.
Vanderporten E; Frick L; Turincio R; Thana P; Lamarr W; Liu Y
Anal Biochem; 2013 Oct; 441(2):115-22. PubMed ID: 23871998
[TBL] [Abstract][Full Text] [Related]
3. An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C).
Swingle M; Volmar CH; Saldanha SA; Chase P; Eberhart C; Salter EA; D'Arcy B; Schroeder CE; Golden JE; Wierzbicki A; Hodder P; Honkanen RE
SLAS Discov; 2017 Jan; 22(1):21-31. PubMed ID: 27628691
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
Duckworth BP; Aldrich CC
Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
[TBL] [Abstract][Full Text] [Related]
5. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
Cao W; Fang L; Teng S; Chen H; Wang Z
Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
[TBL] [Abstract][Full Text] [Related]
6. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
Gul S; Hadian K
Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
[TBL] [Abstract][Full Text] [Related]
8. A bioluminogenic HDAC activity assay: validation and screening.
Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
[TBL] [Abstract][Full Text] [Related]
9. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Mechanism of Inhibition.
Davies G; Semple H; McCandless M; Cairns J; Holdgate GA
SLAS Discov; 2021 Feb; 26(2):248-256. PubMed ID: 33482076
[TBL] [Abstract][Full Text] [Related]
11. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
[TBL] [Abstract][Full Text] [Related]
12. Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.
Honarnejad S; van Boeckel S; van den Hurk H; van Helden S
SLAS Discov; 2021 Feb; 26(2):192-204. PubMed ID: 32734803
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6.
Soikkeli A; Kurkela M; Hirvonen J; Yliperttula M; Finel M
Assay Drug Dev Technol; 2011 Oct; 9(5):496-502. PubMed ID: 21438674
[TBL] [Abstract][Full Text] [Related]
14. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
Swingle MR; Honkanen RE
Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Fluorescence-Based Activity Assay for Arginase-1.
Grobben Y; Willemsen-Seegers N; Uitdehaag JCM; de Man J; van Groningen J; Friesen J; van den Hurk H; Buijsman RC; Zaman GJR
SLAS Discov; 2020 Oct; 25(9):1018-1025. PubMed ID: 32418491
[TBL] [Abstract][Full Text] [Related]
17. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
[TBL] [Abstract][Full Text] [Related]
18. A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase.
Martinez NJ; Asawa RR; Cyr MG; Zakharov A; Urban DJ; Roth JS; Wallgren E; Klumpp-Thomas C; Coussens NP; Rai G; Yang SM; Hall MD; Marugan JJ; Simeonov A; Henderson MJ
Sci Rep; 2018 Jun; 8(1):9472. PubMed ID: 29930256
[TBL] [Abstract][Full Text] [Related]
19. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
20. A fluorescent HTS assay for phosphohydrolases based on nucleoside 5'-fluorophosphates: its application in screening for inhibitors of mRNA decapping scavenger and PDE-I.
Baranowski MR; Nowicka A; Jemielity J; Kowalska J
Org Biomol Chem; 2016 May; 14(20):4595-604. PubMed ID: 27031609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
